



Eclampsia is one of the spectra and clinical manifestation of 
hypertensive disorder of pregnancy.[1] It continues to be one 
of the leading causes of maternal and perinatal morbidity and 
mortality accounting for 11% of the total maternal deaths 
in Nigeria.[1,2] This constitutes a significant reproductive 
health issue and indicates the poor performance status of the 
health-care system.[2]
Eclampsia is the occurrence of tonic–clonic convulsions in 
a patient with preeclampsia in the absence of an underlying 
neurological disease.[3] It is estimated that the prevalence of 
eclampsia is 0.3% worldwide.[4] The incidence in developed 
countries has been relatively stable at 1.6–10 cases per 10,000 
deliveries (0.0016%–0.001%),[5,6] while the incidence of 
eclampsia varies across the geographical location in developing 
countries with reported values of 0.16%–0.7%.[7] This variation 
reflects	the	differences	in	health‑seeking	behaviors,	quality	of	
obstetric care, and the proportion of pregnancies attended to 
by skilled birth attendants. Furthermore, the high incidence of 
eclampsia in the developing countries when compared with 
developed countries are attributable to delay in seeking health 
care, inadequate antenatal care, and challenges in detection and 
prevention of preeclampsia.[8] In Nigeria, institutional-based 
studies reported an overall incidence of between 0.9% and 
2.1% of eclampsia.[9-11]
Context: Eclampsia is one of the leading causes of maternal and perinatal morbidity and mortality in developing countries. This is the result 
of poor health-seeking behavior of pregnant women and inadequate comprehensive emergency obstetric services. This study reviewed the 
presentation and management of eclampsia in Sagamu over a 5-year period. Aims: This study aims to determine the prevalence, pattern of 
clinical presentation and fetomaternal outcomes of eclampsia. Settings and Design: This was a retrospective study conducted in Olabisi 
Onabanjo	University	Teaching	Hospital	Sagamu,	Ogun	state.	Subjects and Methods: Relevant information was retrieved from case notes of all 
patients	who	presented	with	eclampsia	from	January	2014	to	December	2018.	Data	were	analyzed	using	SPSS	version	21.	Results: Out of the 
4656 deliveries, there were 45 cases of eclampsia giving a prevalence of 0.97%. The modal age was 20–24 years. Majority were unbooked 
41 (91.1%) and 29 (64.4%) of the women were nulliparas. Antepartum eclampsia was commonest occurring in 36 women (80%). The most 
common premonitory symptom was headache occurring in as high as 37 women (82.2%). Most of the patients 37 (84.4%) had an abdominal 
delivery.	There	were	 two	maternal	mortalities	 (4.4%)	and	 four	perinatal	deaths	 (8.9%).	There	was	no	statistically	significant	association	
between	factors	such	as	booking	status,	type	of	eclampsia,	mode	of	delivery	and	parity,	and	the	fetal	outcome	(APGAR	score	at	1	min).	
Conclusions: Eclampsia is still one of the preventable causes of maternal and perinatal mortality in our environment. The prevalence of 
eclampsia in sagamu was 0.97%. Improved health-seeking behavior, antenatal care monitoring, and prompt diagnosis and management of 
preeclampsia will invariably reduce the prevalence of eclampsia.
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The etiology of eclampsia still remains unclear as the 
mechanism responsible for preeclampsia and eclampsia is 
still unknown. The underlying basic pathology is widespread 
endothelial dysfunction and intense vasospasm. Immunologic 
dysfunction, genetic predisposition, defective trophoblastic 
invasion of the spiral arteries of the endometrium, coagulation 
defects, imbalance in prostanoid production and vascular 
endothelial damage, and increased plasma antiphospholipid 
are some of the etiopathogenic mechanisms that have been 
implicated in the development of eclampsia.[3,6]
Ninety percent of eclampsia cases occur after 28 weeks’ 
gestation.[12] The cause of the irritation leading to the seizure 
is quite unclear, but eclampsia had been shown to cause central 
nervous system abnormality such as cerebral over perfusion 
due to loss of autoregulation, cerebral edema, and cerebral 
hemorrhage. Eclampsia and its precursor severe preeclampsia 
affect multiple organ systems leading to complications such as, 
hepatic rupture, hemolysis, elevated liver enzymes low platelet, 
acute kidney injury, pulmonary edema, cerebrovascular 
accident, retinal detachment, cortical blindness, disseminated 
intravascular coagulopathy, and eventual maternal death.[13] 
Placental	perfusion	 is	 reduced	 in	 this	disease	 and	 this	may	
result in intrauterine growth restriction and oligohydramnios. 
Other complications include placental abruption, preterm 
delivery, intrauterine asphyxia, and perinatal death. The 
principles of management are initial basic resuscitation, control 
of blood pressure, control and prevent further convulsion. 
A cervical examination is done to determine the favorability 
of the cervix and delivery by the fastest means is instituted 
after adequate stabilization.
In recent time, prevention is being advocated through 
identification of people at risk and early detection of 
pre-eclampsia.[12] A previous review of the presentation and 
management outcome of eclampsia in Olabisi Onabanjo 
University	Teaching	Hospital	 (OOUTH)	was	 done	 during	
a period when the recommendations from the Magpie 
collaborative trial had not been fully implemented in the 
hospital.[13,14]
Hence,	this	study	was	designed	to	determine	the	prevalence	of	
eclampsia, review pattern of presentation, and feto-maternal 




South-west Nigeria. The hospital serves as a referral center 
for obstetrics and gynecological services from neighboring 
towns and villages in Ogun state and Lagos state. This was a 
retrospective study involving the review of patients diagnosed 
as having eclampsia between January 1, 2014 and December 
31, 2018.
The case notes of all patients diagnosed with eclampsia were 
retrieved from the central medical record and labor ward. 
Information obtained was documented in the data capture 
sheet. The information includes age of patient, parity, booking 
status occupation, educational status, referral facility, blood 
pressure at presentation, level of proteinuria, premonitory 
symptoms, and episodes of convulsion. Other details retrieved 
were estimated gestational age at delivery, mode of delivery, 
birth outcome, Apgar scores, and maternal complications. 
Babies	that	had	APGAR	scores	<3	at	1	min	were	classified	as	
having severe birth asphyxia.
Ethical	approval	for	the	study	was	obtained	from	the	Health	
Research	Ethics	Committee	of	OOUTH,	Sagamu.
The research was conducted in accordance with the World 
Medical	Association	Declaration	of	Helsinki.
The	data	were	entered	into	IBM‑SPSS	version	21	(IBM	Corp,	
Armonk, NY, USA). Categorical variables were summarized 
using frequencies and percentages while means and standard 
deviations were used for continuous variables. Chi-square test 
was used to determine the relationship between categorical 
variables. P <	0.05	was	taken	as	statistically	significant.
Results
During the period under review, there were 4656 deliveries 
and 45 cases of eclampsia, thus giving a prevalence of 9.67 
per 1000 deliveries (0.97%).
Table 1 shows the sociodemograpghic statistics. The mean 
age was 24.4 ± 8.9 years with an age range of 19–42 years. 
Majority of the women affected were within the age group 
of 20–24 years (46.7%). The mean parity for the study was 
1.24 ± 0.87. The median parity is 0. The parity ranges from 0 
to 5. Nulliparity accounted for 64.4% of the studied group. The 
majority 41 (91.1%) of the pregnant women were unbooked. 
Most of the women had at least a secondary education. Among 
the study group, 13 (31.4%) cases were referred from private 
hospitals, 8 (17.8%) cases were not referred, 7 (15.6%) 
cases were referred from government general hospital, 
6 (13.3%) cases were referred from primary health centers, 
5 (11.1%) cases had visited traditional birth attendant prior to 
presentation, and 2 (4.4%) cases came from church.
Table 2 shows that the mean systolic and diastolic blood 
pressures	were	180.44	±	23.82	mmHg	and	113.89	±	16.47	mmHg,	
respectively. All the women had an elevated level of blood 
pressure at presentation. Forty women (88.9%) presented 
with severe systolic blood pressure while 5 (11.1%) had mild 
systolic pressure. The diastolic pressure also showed that 
31 (68.9%) had severe diastolic pressure and 14 (31.1%) cases 
had mild diastolic pressure.
Three (6.7%) of the cases reviewed had proteinuria of 1+, 
23 (51.1%) had 2+ of proteinuria, 17 (37.8%) of the cases had 
3 + proteinuria and one woman each (2.2%) had 4 + proteinuria 
and negative proteinuria.
Antepartum eclampsia was the most common clinical 
type occurring in 36 (80%) of cases, 5 cases (11.1%) were 
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intrapartum eclampsia and 4 (8.9%) were postpartum 
eclampsia. Twenty-two (48.9%) cases had one convulsion 
prior	 to	 presentation	 in	OOUTH,	 8	 (17.8%)	 had	 two	 and	
15 (33.3%) had three or more convulsions. The mean number 
of convulsions was 2.3 ± 1.7.
Table 3 shows the distribution of prodromal symptoms 
associated with Eclampsia. Thirty-seven (82.2%) women 
presented with headache, 18 (40%) presented with blurring of 
vision and 18 (40.0%) had altered sensorium at presentation. 
Only three (6.7%) had spontaneous vaginal delivery, 4 (8.9%) 
had instrumental delivery and 38 (84.4%) had cesarean 
section. The mean gestational age was 36.5 ± 5.4 weeks. 
However,	 26	women	 (57.8%)	were	 delivered	 at	 estimated	
gestational age of 37 weeks and above while 19 (42.2%) of 
the eclamptic patients were delivered at estimated gestational 
age below 37 weeks. All cases of eclampsia occurred in the 
third trimester.
Table 4 depicts the maternal complication following eclampsia. 
Seven	(15.56%)	had	HELLP	syndrome,	6	(13.3%)	had	acute	
kidney injury, 4 (8.89%) had acute pulmonary edema, and 
2 (4.44%) had cerebrovascular disease. There were 2 (4.44%) 
maternal deaths.
Table 5 shows fetal complications. Twenty-nine women (64.4%) 
delivered babies that had perinatal asphyxia, and 23 of 
the neonates required neonatal ward admission. Fourteen 
women (31.1%) had no complications. The mean Apgar score 
at 1 min was 4.9 ± 2.9. There were 2 (4.4%) stillbirths and 
4 (8.9%) perinatal deaths.
Severe	birth	asphyxia	(APGAR	score	≤3)	was	more	common	
among unbooked patients, patients with intrapartum 
eclampsia, babies delivered through cesarean section and 
nulliparous	 patients.	There	was	 no	 statistically	 significant	
association between booking status, types of eclampsia, mode 
of delivery and parity, and the occurrence of severe birth 
asphyxia	(APGAR	score	at	1	min	≤3)	(P	=	0.644, P =	0.455, 
P =	0.674, P =	0.654,	respectively)	[Table 6].





















Civil servant 8 (17.8)
Professional 6 (13.3)
Educational status




Table 2: Distribution of classical case definition of 
eclampsia (blood pressure, degree of proteinuria, and 
number of convulsion) (n=45)
Variable Frequency (%)
Blood	pressure
Mild systolic pressure 5 (11.1)
Severe systolic pressure 40 (88.9)
Mild diastolic pressure 14 (31.1)












Table 3: Prodromal symptoms associated with eclampsia






Altered sensorium 18 (40.0)
Table 4: Maternal complications of eclampsia
Complications Frequency (%)
Acute renal failure 6 (13.3)
Papilledema 16 (35.6)
Cerebrovascular disease 2 (4.44)
Anemia 2 (14.29)
Tongue laceration 1 (2.22)
Fracture mandible 1 (2.22)
Acute pulmonary edema 4 (8.89)
Maternal mortality 2 (4.44)
HELLP	syndrome 7 (15.56)
HELLP:	Heamolysis	elevated	low	platelet
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dIscussIon
Eclampsia remains one of the leading causes of maternal and 
perinatal mortality and morbidity in the developing world.[2,3] 
This study was designed to assess the prevalence, clinical 
presentation and the management outcome of eclampsia in 
Sagamu.
The prevalence of 0.97% found in this study is higher 
than 0.91% and 0.65% reported in Ile-Ife and Nnewi.[10,11] 
This rate is however much lower than 1.3%, 2.7%, 2.1%, 
and 9.42% reported in, Abuja, Imo, Osogbo and Jigawa, 
respectively .[8,9,15,16] All of these were tertiary hospital-based 
studies. Furthermore, the prevalence of 0.97% is lower than 
1.7% reported by Olatunji and Sule-Odu[13] in this health 
facility 15 years ago. This can be attributed to early referral of 
preeclamptic cases for expert management (before progression 
to eclampsia) by caregivers in nearby primary and secondary 
health facilities.
Majority were within the age group of 20–24 years, similar 
to	findings	 in	Gwagwalada,	Abuja.[9] This is the age range 
during	which	many	women	are	carrying	their	first	pregnancies	
and nulliparity is a recognized risk factor for preeclampsia. 
It is worthy of note that the modal age group for eclampsia 
in a previous study done in Sagamu was 15–19 years of age 
group.[13] This may suggest that the various campaigns against 
early marriage and advocating for girl child education and 
empowerment by various nongovernmental organization have 
started yielding fruits. Almost two-thirds of the women with 
eclampsia	 in	 this	 study	were	 nulliparous;	 similar	 findings	
were also reported in other studies.[8,13,15,16] This study shows 
that nulliparous women in their early twenties were the most 
vulnerable group. It is imperative to provide adequate health 
education about the condition of this group of women to 
enhance their health-seeking behavior.
Majority (91.1%) of the patients were unbooked, similar to 
studies from different parts of the country.[13,14,17] Only a few of 
the women with eclampsia were booked patients. This could be 
as a result of strict and effective monitoring of pregnant women 
during antenatal clinic, early detection and management of 
cases of preeclampsia and prophylactic use of magnesium 
sulfate among women with severe preeclampsia.
The most common clinical type of eclampsia encountered in 
this review was antepartum eclampsia accounting for 80%. 
This is not surprising for a developing country like Nigeria, 
where health-seeking behavior is poor, and antenatal care and 
delivery in health facilities have been reported to be low. This 
finding	that	four‑fifth	of	the	patients	had	antepartum	eclampsia	
was consistent with several studies in this country[11-13,15] but 
differs	from	findings	in	developed	countries	where	postpartum	
eclampsia tends to be more common.[8] This has been ascribed 
to improvement in prenatal care, screening and early detection 
of preeclampsia and prophylactic use of magnesium sulfate 
in the management of severe preeclampsia in developed 
countries.[8]
The most common clinical presentations encountered in this 
review include elevated blood pressure, headache, blurring of 
vision, and altered sensorium. These are the most commonly 
reported symptoms of imminent eclampsia occurring before 
the onset of convulsion. This suggests that closely monitoring 
patients with these symptoms may provide an early warning 
for	eclampsia.	Proteinuria	was	also	not	found	in	one	of	 the	
patients. This suggests that eclampsia can occur in patients 
with gestational hypertension (nonproteinuric hypertension). 
Mustafa et al.[18] reported that approximately 30% of eclamptic 
patients	had	no	ominous	proteinuria.	This	finding	could	inform	
the use of prophylactic magnesium sulfate in patients with 
severe gestational hypertension. In this study, all women had 
elevated blood pressure ranging from mild to severe systolic or 
diastolic	blood	pressure.	However,	previous	studies	had	shown	
that approximately 16% and 38% of eclamptic patients were 
normotensive	in	the	United	Kingdom	and	the	United	States,	
respectively.[19,20]
In this present study, majority were delivered through 
emergency	cesarean	section.	This	was	consistent	with	findings	
from other studies.[6,7,11] This was not surprising as eclamptic 
patients are expected to be delivered in a timely fashion. It is 
therefore important that health policy makers should support 
the provision of more comprehensive emergency obstetrics 
care centers where eclampsia could be adequately managed 
so as to prevent mortality and morbidity associated with the 
Table 6: The association between booking status, type of 
eclampsia, mode of delivery, parity, and Apgar scores at 
1 min of delivery






Booked 1 (25.0) 3 (75.0) 0.2135 0.644053
Unbooked 15 (48.4) 16 (51.6)
Type of eclampsia
Antepartum 13 (36.1) 23 (63.8) 1.576 0.45476
Intrapartum 3 (60.0) 2 (40.0)
Postpartum 0 (0.0) 4 (100.0)
Mode of delivery
Vaginal delivery 2 (28.6) 5 (71.4) 0.1765 0.674429
Cesarean section 14 (36.8) 24 (63.2)
Parity
Nulliparity 11 (37.9) 18 (62.1) 0.2009 0.654025
Primi/multiparity 5 (31.3) 11 (68.7)




Early neonatal death 2 (2.2)
Prematurity 19 (42.2)
Neonatal admission 23 (51.1)
Nil 14 (31.1)
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condition. The maternal mortality was 4.4%, mainly from 
cerebral hemorrhages and renal failure. This rate was lower 
than 5.3% reported in Abuja.[9] A possible reason for the 
lower death rate in this study is the fact that all eclamptics in 
this study were managed with magnesium sulfate according 
to	 the	 Pritchard	 regimen	whereas	 diazepam	was	 the	main	
anticonvulsant available during the study in Abuja. The 
relatively low perinatal mortality could also be due to prompt 
delivery of the fetus and use of magnesium sulfate.
This study revealed no significant association between 
booking status, type of eclampsia, mode of delivery, parity, 
and	 the	occurrence	of	severe	birth	asphyxia	 (APGAR	score	
at	1	min	≤3).	This	underscores	the	importance	of	ensuring	a	
multidisciplinary approach in the management of all cases of 
eclampsia. Women with eclampsia should be managed by a 
team of senior obstetricians, anesthetics, hematologists and 
neonatologists. This is important for both maternal and neonatal 
survival and avoidance of any chronic or debilitating sequelae.
conclusIons
The	prevalence	of	eclampsia	in	sagamu	was	0.97%.	Headache	
and visual disturbance were the commonest prodromal 
symptoms. Eclampsia remains a preventable cause of maternal 
and perinatal mortality in our environment. It is important 
to create public awareness, encourage pregnant women to 
assess antenatal care facilities and to improve comprehensive 
emergency obstetrics services across the secondary health 
facilities. Furthermore, a multidisciplinary approach in the 
management of cases will ensure improve obstetrics outcomes.
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